National Covid-19: Covovax To Get Approval As Booster In 10-15 Days, Says SII CEO Adar Poonawalla BY PTI
National Serum Institute Seeks Emergency Use Authorisation For Its rBCG Tuberculosis Vaccine BY Outlook Web Desk
International Reinfection With Different Subtypes Of Omicron Possible, Study Finds BY Outlook Web Desk